Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Exponent Inc. (EXPO) Stock Forecast & Price Prediction United States | NASDAQ | Industrials | Engineering & Construction
$79.15
+0.16 (0.20%)10 Quality Stocks Worth Considering Now
Researching Exponent (EXPO) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on EXPO and similar high-potential opportunities.
Based on our analysis of 4 Wall Street analysts, EXPO has a neutral consensus with a median price target of $108.00 (ranging from $96.00 to $120.00). Currently trading at $79.15, the median forecast implies a 36.4% upside. This outlook is supported by 1 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Tobey Sommer at Truist Securities, projecting a 51.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for EXPO.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Jul 26, 2024 | Truist Securities | Tobey Sommer | Buy | Reiterates | $120.00 |
Apr 29, 2024 | Truist Securities | Tobey Sommer | Buy | Maintains | $100.00 |
Feb 2, 2024 | Truist Securities | Tobey Sommer | Buy | Maintains | $95.00 |
Jul 31, 2023 | Truist Securities | Tobey Sommer | Buy | Maintains | $110.00 |
Jun 1, 2023 | UBS | Joshua Chan | Neutral | Initiates | $99.00 |
Apr 5, 2022 | Truist Securities | Tobey Sommer | Buy | Maintains | $120.00 |
Aug 2, 2021 | Truist Securities | Tobey Sommer | Buy | Maintains | $118.00 |
Jun 2, 2020 | Sidoti & Co. | Buy | Maintains | $94.00 | |
May 13, 2020 | Sidoti & Co. | Buy | Upgrade | $0.00 | |
May 1, 2020 | Sidoti & Co. | Neutral | Maintains | $80.00 | |
Mar 19, 2020 | Sidoti & Co. | Marc Riddick | Buy | Upgrade | $78.00 |
Feb 7, 2020 | Sidoti & Co. | Neutral | Maintains | $74.00 | |
Oct 3, 2019 | Sidoti & Co. | Neutral | Maintains | $72.00 | |
Sep 20, 2019 | SunTrust Robinson Humphrey | Buy | Maintains | $81.00 | |
Aug 29, 2019 | DA Davidson | Neutral | Initiates | $0.00 | |
Jan 26, 2018 | SunTrust Robinson Humphrey | Buy | Upgrade | $0.00 | |
Aug 26, 2016 | Cantor Fitzgerald | Buy | Initiates | $0.00 |
The following stocks are similar to Exponent based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Exponent Inc. has a market capitalization of $4.02B with a P/E ratio of 37.5x. The company generates $518.49M in trailing twelve-month revenue with a 21.0% profit margin.
Revenue growth is +8.7% quarter-over-quarter, while maintaining an operating margin of +22.0% and return on equity of +28.1%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provides engineering and scientific consulting services.
Exponent Inc. operates as a consulting firm that generates revenue by offering specialized analysis and solutions to businesses, industries, and government agencies across various sectors. The company charges clients for its expertise in risk analysis, product safety, and failure analysis, which are critical for compliance with regulatory standards and improving system performance.
Founded in 1967, Exponent has built a strong reputation by serving a diverse range of clients, including Fortune 500 companies, law firms, governmental bodies, and insurance companies. Its multidisciplinary team of experts ensures reliable investigations and recommendations, positioning the firm as a leader in knowledge-based consulting services.
Industrials
Engineering & Construction
1,168
Dr. Catherine Ford Corrigan P.E., Ph.D.
United States
1990
Exponent, Inc. (Nasdaq: EXPO) will report Q1 fiscal 2025 results on May 1, 2025, after market close. A conference call with executives will follow at 4:30 p.m. ET.
Exponent, Inc.'s upcoming financial results announcement and conference call may impact stock performance, providing insights into the company's growth and financial health.
Exponent Inc. shows strong revenue growth and a 13-year dividend increase. It has a solid balance sheet and competitive advantages, but its premium valuation suggests a hold for investors.
Exponent Inc.'s strong dividend growth, solid balance sheet, and competitive advantages signal stability, but its premium valuation suggests caution for potential buyers.
This week, 31 companies announced dividend increases, including Dividend Kings Genuine Parts, Commerce Bancshares, and Kimberly-Clark, indicating financial stability and growth potential.
The 31 dividend increases, especially from Dividend Kings, signal strong financial health and growth potential, attracting income-focused investors and enhancing portfolio stability.
CAT, CABGY, and EXPO have been assigned a Zacks Rank #5 (Strong Sell) as of February 27, 2025.
CAT, CABGY, and EXPO being added to the Zacks Rank #5 indicates a bearish outlook, suggesting potential declines in their stock prices, which could impact investor sentiment and decisions.
Exponent, Inc. (NASDAQ: EXPO) will hold its Q4 2024 Earnings Conference Call on February 6, 2024, at 4:30 PM ET, featuring key executives and analysts.
The Q4 2024 earnings call for Exponent, Inc. will provide insights into the company's financial performance, future guidance, and market positioning, essential for assessing investment potential.
Exponent (EXPO) reported quarterly earnings of $0.46 per share, surpassing the Zacks Consensus Estimate of $0.40 and up from $0.41 per share year-over-year.
Exponent's earnings beat estimates, indicating strong performance and potential for growth, which can positively influence investor confidence and stock price.
Based on our analysis of 4 Wall Street analysts, Exponent Inc. (EXPO) has a median price target of $108.00. The highest price target is $120.00 and the lowest is $96.00.
According to current analyst ratings, EXPO has 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $79.15. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict EXPO stock could reach $108.00 in the next 12 months. This represents a 36.4% increase from the current price of $79.15. Please note that this is a projection by Wall Street analysts and not a guarantee.
Exponent Inc. operates as a consulting firm that generates revenue by offering specialized analysis and solutions to businesses, industries, and government agencies across various sectors. The company charges clients for its expertise in risk analysis, product safety, and failure analysis, which are critical for compliance with regulatory standards and improving system performance.
The highest price target for EXPO is $120.00 from Tobey Sommer at Truist Securities, which represents a 51.6% increase from the current price of $79.15.
The lowest price target for EXPO is $96.00 from at , which represents a 21.3% increase from the current price of $79.15.
The overall analyst consensus for EXPO is neutral. Out of 4 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $108.00.
Stock price projections, including those for Exponent Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.